West Pharma Announces Fourth-Quarter and Full-Year 2019 Results


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ West Pharma Announces Fourth-Quarter and Full-Year 2019
West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance.

Fourth-Quarter and Full-Year 2019 Summary (comparisons to prior-year period)

Fourth-quarter 2019 net sales of $470.6 million grew 11.4%; organic sales growth was 12.7%; sales from a recent acquisition contributed an additional 30 basis points of growth; currency translation reduced sales by 160 basis points.

Full-year 2019 net sales of $1.840 billion grew 7.1%; organic sales growth was 10.0%; sales from a recent acquisition contributed an additional 10 basis points of growth; currency translation reduced sales by 300 basis points.

Fourth-quarter 2019 reported-diluted EPS of $0.84 increased 22%. Full-year 2019 reported-diluted EPS of $3.21 increased 17%.

Fourth-quarter 2019 adjusted-diluted EPS of $0.82 increased 12%. Full-year 2019 adjusted-diluted EPS of $3.24 increased 15%.

Company is introducing full-year 2020 financial guidance of net sales in a range of $1.95 billion to $1.97 billion and reported-diluted EPS in a range of $3.45 to $3.55.

"Adjusted-diluted EPS" and "organic sales growth" are Non-U.S. GAAP measurements. See discussion under the heading "Non-U.S. GAAP Financial Measures" in this release.

"I am pleased to report strong fourth-quarter 2019 sales and EPS growth, which continues a trend seen throughout the year," said Eric M. Green, President and Chief Executive Officer. "We had double-digit organic sales growth in all three market units of our Proprietary Products segment. High-value products (HVPs) once again fueled sales growth and gross margin expansion, led by Daikyo® and Westar® components."

Mr. Green continued, "We are introducing full-year 2020 financial guidance that is in line with our long-term financial construct of organic sales growth and operating margin expansion. Our end markets are stable and growing, and we are off to a good start to 2020 with a strong book of committed orders for our high value products, such as NovaPure® and Envision® components, as well as Daikyo Crystal Zenith® containers and our portfolio of self-injection delivery platforms. Our teams across the globe have demonstrated their passion for customers throughout 2019, with new product and services offerings, and are poised to deliver another strong year of sales and profit growth for our business in 2020."

Tags : #Westpharma #Q4result #Financialguidancefor2020

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Dark Web Health Data: Why Medical Records MatterOctober 27, 2026
Can Conversational AI Improve Patient Follow-Up After Discharge?October 27, 2026
UAE fast-tracking advanced diagnostics as global market heads for US$152 billionOctober 26, 2026
How Digital Check-In Can Support More Accessible Patient JourneysOctober 26, 2026
The Role of Consent Communication in Digital Healthcare ServicesOctober 26, 2026
How Data Analytics Is Transforming Hospital Decision-MakingOctober 26, 2026
Hospital Intelligence: The Next Big Leadership Shift in India October 26, 2026
What Patients Should Expect From a Well-Designed Health Checkup ProgrammeOctober 23, 2026
Building Stronger Community-Based Screening ProgrammesOctober 23, 2026
Gulf Medical University Ranks 1st for International Student Ratio in QS Arab Region Rankings 2027October 22, 2026
Arthritis Is Not Just an Elderly Person's Disease: Why Younger Adults Are Also Developing Joint ProblemsOctober 22, 2026
Krishna Automotive strengthens its operations in Hyderabad. Enhances customer offering with BMW Service Workshop and BMW Premium Selection.October 22, 2026
CTR-JK Tyre FMSCI Indian National Car Racing Championship 2026 set for season opener in CoimbatoreOctober 22, 2026
The Anonymous Indian Charitable Trust (TAICT) Wins Sustainable Organization Award 2026October 22, 2026
Vinod Intelligent Cookware Targets Delhi’s Premium Cookware Market with Freya Brand ActivationOctober 22, 2026
Apollo Hospitals and Avadi Police Commissionerate Organise Health Camp for Police Personnel and Their Families Under ‘Kaval Kudumbam’ SchemeOctober 22, 2026
TAMPOS Midterm Conference 2026 Brings Together 150 Oncologists to Advance Cancer Care Across Tamil NaduOctober 22, 2026
Shades of Pink: Apollo Athenaa Women's Cancer Centres puts the spotlight on breast health awarenessOctober 22, 2026
How Health Systems Can Reduce Missed Follow-UpsOctober 21, 2026
What Good Care Coordination Looks Like Across Multiple ProvidersOctober 21, 2026